Position in CYTK
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$4,545,568
+$2,323,347 QoQ
Shares Held
53,358
+58.3% QoQ
Ownership
0.038%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#170
of 477 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CYTK Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026NATIXIS ADVISORS, LLC holds $495,549,179 across 38 Biotechnology names. CYTK ranks #12 (0.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
448,631 | $222,848,476 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
129,236 | $80,583,815 | |
| 3 | TECH |
BIO-TECHNE Corp
|
818,905 | $57,855,638 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
75,311 | $22,670,870 | |
| 5 | ARGX |
Argenx SE
|
19,088 | $17,709,273 | |
| 6 | INSM |
INSMED Inc
|
73,607 | $7,847,978 | |
| 7 | HALO |
Halozyme Therapeutics, Inc.
|
97,536 | $7,634,142 | |
| 8 | JAZZ |
Jazz Pharmaceuticals plc
|
29,928 | $7,211,749 |
All Filings in CYTK
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,545,568 | 53,358 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $2,222,221 | 33,716 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $1,667,925 | 26,250 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $1,240,007 | 22,562 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $610,347 | 18,473 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $1,827,238 | 45,465 | Shares | Defined | 2025-05-08 | |
| 2024-12-31 | $1,583,319 | 33,659 | Shares | Defined | 2025-02-10 | |
| 2024-09-30 | $1,985,016 | 37,595 | Shares | Defined | 2024-11-06 | |
| 2024-06-30 | $2,570,353 | 47,441 | Shares | Defined | 2024-08-01 | |
| 2024-03-31 | $3,538,872 | 50,476 | Shares | Defined | 2024-04-25 | |
| 2023-12-31 | $5,256,697 | 62,962 | Shares | Defined | 2024-02-06 | |
| 2023-09-30 | $1,291,467 | 43,838 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $1,582,167 | 48,503 | Shares | Defined | 2023-08-15 | |
| 2023-03-31 | $1,402,356 | 39,851 | Shares | Defined | 2023-05-11 | |
| 2022-12-31 | $1,546,287 | 33,747 | Shares | Defined | 2023-01-27 | |
| 2022-09-30 | $1,754,132 | 36,205 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,374,717 | 34,989 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $822,629 | 22,348 | Shares | Defined | 2022-05-12 | |
| 2021-12-31 | $1,034,027 | 22,686 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $704,649 | 19,716 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $339,180 | 17,139 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $416,609 | 17,911 | Shares | Defined | 2021-05-05 | |
| 2020-12-31 | $392,367 | 18,882 | Shares | Defined | 2021-02-12 | |
| No filing history on record for this holder in this stock. | ||||||